Replies to post #422917 on Amarin Corp Plc (AMRN)

[hayward]

ziploc 1

I hope not because at that point it would be prescribed as off label ! IMO they need to bury the generics once and for all ! What good did the settlement do for us in regards to the health net settlement ? This non disclosure bullshit has to end so everyone knows the outcome

Michael

[Jasbg]

ziploc, Even the Du Disaster could be reversed - (as ruling were based on fraud) the loss of generic Vascepa will hardly be noticeable at Hikma and Dr Ready.

https://www.hikma.com/what-we-do/products/ (still 759 products left)

Our business goals for the region include expanding our portfolio to nearly 335+ products (June ’23).

https://www.drreddys.com/articles?4#39ef23b6-c634-4998-ae00-891c57a19c7b

( Dr Ready down to 334 products) 🙂

These are BIG Companies with thousands of employes.

For Hikma and Dr Ready the ANDA case win over Amarin - were purely routine for their permanet law specialists - in winning these cases against small 'one drug patent holders' - like Amarin.

[DAR53]

And help me understand why Amarin would forego the treble damages. If the Generics (Hikma or others) were found to be guilty of infringement, they should automatically cease to infringe in the CVD space. I would certainly make them pay for the damages.

[DAR53]

So, you are suggesting a safer route and just settle. That in the past with HealthNet did not appear to have much benefit to Amarin. And, if we simply settle would not the Hikma generic market be then split between the other remaining generics which in the end does not benefit Amarin at all.
Am I missing something?
TIA for any clarifications.